James E Everhart

Author PubWeight™ 158.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 2008 9.33
2 The burden of selected digestive diseases in the United States. Gastroenterology 2002 6.79
3 Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004 5.83
4 Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr 2008 5.01
5 Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003 4.95
6 Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 2009 4.90
7 The prevalence of celiac disease in the United States. Am J Gastroenterol 2012 4.77
8 Daily activity energy expenditure and mortality among older adults. JAMA 2006 4.36
9 Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology 2004 4.27
10 Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009 3.50
11 Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials 2004 3.46
12 Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005 3.12
13 Relationship of hepatitis C virus infection with diabetes in the U.S. population. Hepatology 2014 3.04
14 Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007 2.72
15 Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology 2002 2.64
16 Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005 2.64
17 Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol 2005 2.63
18 Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2008 2.63
19 Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol 2005 2.51
20 Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology 2010 2.47
21 The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006 2.43
22 A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003 2.37
23 Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2008 2.30
24 Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med 2011 2.07
25 Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007 2.07
26 Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011 2.01
27 Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology 2011 1.98
28 Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 2013 1.95
29 Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005 1.93
30 Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hepatology 2003 1.87
31 Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst 2010 1.81
32 Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005 1.76
33 Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol 2007 1.71
34 Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010 1.70
35 Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Gastroenterology 2010 1.67
36 Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004 1.59
37 Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2011 1.59
38 A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med 2003 1.58
39 Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology 2010 1.52
40 Energy requirements in the eighth decade of life. Am J Clin Nutr 2004 1.46
41 Risk factors for inguinal hernia among adults in the US population. Am J Epidemiol 2007 1.45
42 Diabetes increases the risk of acute hepatic failure. Gastroenterology 2002 1.39
43 Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology 2009 1.35
44 A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Hepatology 2011 1.33
45 Gallstone disease is associated with increased mortality in the United States. Gastroenterology 2010 1.32
46 Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology 2007 1.31
47 Water turnover in 458 American adults 40-79 yr of age. Am J Physiol Renal Physiol 2003 1.24
48 Body composition data for individuals 8 years of age and older: U.S. population, 1999-2004. Vital Health Stat 11 2010 1.24
49 A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology 2013 1.21
50 Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology 2003 1.19
51 Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology 2009 1.18
52 Influence of delayed isotopic equilibration in urine on the accuracy of the (2)H(2)(18)O method in the elderly. J Appl Physiol (1985) 2002 1.15
53 Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg 2010 1.13
54 HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology 2006 1.13
55 Serum leptin concentrations and body adipose measures in older black and white adults. Am J Clin Nutr 2004 1.10
56 Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology 2012 1.10
57 Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 2002 1.10
58 Activity energy expenditure and change in body composition in late life. Am J Clin Nutr 2009 1.09
59 Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies. J Infect Dis 2014 1.07
60 An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. PLoS One 2011 1.04
61 Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. Am J Clin Nutr 2007 1.03
62 Activity energy expenditure and mobility limitation in older adults: differential associations by sex. Am J Epidemiol 2009 1.02
63 Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology 2011 1.02
64 Modifiable environmental and behavioral determinants of overweight among children and adolescents: report of a workshop. Obesity (Silver Spring) 2006 0.98
65 Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology 2010 0.96
66 Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C. Hepatology 2008 0.91
67 Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl 2013 0.91
68 Physical activity and gallbladder disease determined by ultrasonography. Med Sci Sports Exerc 2007 0.90
69 Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2014 0.89
70 Fatty liver: think globally. Hepatology 2010 0.87
71 Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains. Hepatology 2003 0.84
72 Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology 2008 0.84
73 Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl 2013 0.81
74 Longitudinal change in energy expenditure and effects on energy requirements of the elderly. Nutr J 2013 0.80
75 Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7). Pharmacogenet Genomics 2011 0.80
76 The association of low serum alanine aminotransferase activity with mortality in the US population. Am J Epidemiol 2013 0.80
77 Epidemiologic research and the action plan for liver disease research. Ann Epidemiol 2006 0.79
78 Is cirrhosis an inevitable consequence of chronic hepatitis C virus infection? Clin Gastroenterol Hepatol 2005 0.78
79 The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study. Eur J Epidemiol 2013 0.78
80 A prospective study of dyspepsia in primary care. Dig Dis Sci 2002 0.77
81 Diurnal variation in serum alanine aminotransferase activity in the US population. J Clin Gastroenterol 2013 0.76
82 Non-alcoholic fatty liver disease (NAFLD) and mortality. J Hepatol 2009 0.75
83 Alcohol and hepatitis C: do we have a drinking problem? Gastroenterology 2006 0.75
84 Outcomes among living liver donors. Gastroenterology 2011 0.75